The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Reflux gastritis 6
SANDOSTATIN LAR DEPOT Restlessness 6
SANDOSTATIN LAR DEPOT Seroma 6
SANDOSTATIN LAR DEPOT Skin cancer 6
SANDOSTATIN LAR DEPOT Skin plaque 6
SANDOSTATIN LAR DEPOT Sluggishness 6
SANDOSTATIN LAR DEPOT Stasis dermatitis 6
SANDOSTATIN LAR DEPOT Tendonitis 6
SANDOSTATIN LAR DEPOT Therapeutic response unexpected 6
SANDOSTATIN LAR DEPOT Thrombophlebitis 6
SANDOSTATIN LAR DEPOT Tinnitus 6
SANDOSTATIN LAR DEPOT Tumour pain 6
SANDOSTATIN LAR DEPOT Viral infection 6
SANDOSTATIN LAR DEPOT Yellow skin 6
SANDOSTATIN Abdominal pain lower 5
SANDOSTATIN Blood growth hormone increased 5
SANDOSTATIN Dry skin 5
SANDOSTATIN Full blood count decreased 5
SANDOSTATIN Glycosylated haemoglobin increased 5
SANDOSTATIN Influenza like illness 5

Total Records: 2,045     Number of Pages: 103